Haeberlein Samantha L. Budd - 08 May 2023 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
Director
Signature
/s/ Christopher Verni, Attorney-in-Fact
Issuer symbol
VIGL
Transactions as of
08 May 2023
Net transactions value
$0
Form type
4
Filing time
09 May 2023, 16:10:13 UTC
Next filing
09 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Stock Option Grant (Right to Buy) Award $0 +30,694 $0.000000 30,694 08 May 2023 Common Stock 30,694 $9.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in thirty-six (36) equal monthly installments, with the first installment vesting on June 8, 2023.